IHRE BESTELLUNG
Ihr Warenkorb ist leer
Fügen Sie Forschungspeptide zu Ihrem Warenkorb hinzu.
DAS KÖNNTE IHNEN AUCH GEFALLEN
Ihr Warenkorb ist leer
Fügen Sie Forschungspeptide zu Ihrem Warenkorb hinzu.
DAS KÖNNTE IHNEN AUCH GEFALLEN
Glucagon-Like Peptide-1, an incretin hormone that regulates blood sugar, slows gastric emptying, and reduces appetite, targeted by semaglutide and tirzepatide.
Glucagon-Like Peptide-1 (GLP-1) is a 30-amino acid incretin hormone secreted by L-cells in the intestinal epithelium in response to nutrient ingestion. It exerts its metabolic effects by binding to the GLP-1 receptor, a G-protein-coupled receptor expressed on pancreatic beta cells, the central nervous system, heart, kidney, and gastrointestinal tract. GLP-1's primary actions include stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and signalling satiety to the brain via vagal afferents and direct hypothalamic action. Native GLP-1 has a very short half-life of approximately 2 minutes due to rapid degradation by dipeptidyl peptidase-4 (DPP-4), which led to the development of long-acting GLP-1 receptor agonists such as semaglutide and the dual GIP/GLP-1 agonist tirzepatide. These synthetic analogues have transformed metabolic research through sustained receptor activation.
A long-acting GLP-1 receptor agonist peptide used in metabolic research, with a modified structure that extends its half-life to approximately one week.
A first-in-class dual GIP/GLP-1 receptor agonist peptide with superior metabolic efficacy, acting on both incretin pathways simultaneously.
Glucose-dependent Insulinotropic Polypeptide receptor, a key target in metabolic peptide research that mediates insulin secretion and energy homeostasis.
The time required for the concentration of a substance in the body to decrease by 50%, a key pharmacokinetic parameter determining dosing frequency.
The fundamental building blocks of peptides and proteins, with 20 standard types that combine in unique sequences to create biologically active molecules.
Body Protection Compound-157, a synthetic 15-amino acid peptide derived from human gastric juice with potent tissue-healing and neuroprotective properties.
Legal under MHRA rules. BPC-157, tirzepatide & NAD+ pens with next-day UK delivery from £99. >99% purity, GMP certified. Shop now.
ARTICLEPens cut dosing error from 15% to under 2%. We compare accuracy, contamination risk, cost, and convenience. See why researchers are switching in 2026.
ARTICLEOver 100 published studies back BPC-157 for tissue repair, gut healing, and neuroprotection. Mechanisms, dosing protocols, and where to buy in the UK.
COMPARISONVergleichen Sie BPC-157 und TB-500 für die Erholungsforschung. Mechanismen, Vorteile, Dosierung und wann Sie jedes Peptid verwenden sollten. Kaufen Sie beide als vorgemischte Stifte.
COMPARISONVergleichen Sie Tirzepatid und Semaglutid für die metabolische Forschung. Dual- vs. Einzelrezeptor, Wirksamkeitsdaten, Nebenwirkungen und Preise. Tirzepatid-Stifte kaufen.
ENCYCLOPEDIAGastric Pentadecapeptide. Molekulargewicht: 1419.53 Da. Entdecken Sie Wirkmechanismus, Schlüsselstudien und Forschungsanwendungen.
BUNDLEDas klassische Heilungsduo für beschleunigte Gewebereparatur
PROTOCOLForschungsprotokoll mit BPC-157 und TB-500 Peptid-Pens für beschleunigte Gewebeerholung. Erkunden Sie synergistische Heilungsmechanismen, Dosierungspläne und veröffentlichte Studienergebnisse.
FAQAlles über Peptid-Pen-Systeme. Funktionsweise, Vorteile gegenüber Vials und Dosiermechanismen.
CATEGORYResearch-grade recovery peptide pens. BPC-157 and TB-500 for tissue repair, wound healing, and inflammation research. >99% purity, UK delivery.
CATEGORYResearch-grade weight loss peptide pens. Tirzepatide dual GIP/GLP-1 agonist for metabolic research. Pre-mixed pens, >99% purity, next-day UK delivery.
Premium pre-mixed peptide pens with next-day UK delivery. GMP manufactured, >99% purity guaranteed.
SHOP ALL PEPTIDES
